Bio-Techne (TECH) Enterprise Value (2009 - 2026)

Bio-Techne's Enterprise Value history runs 18 years deep, the most recent figure standing at -$209.8 million for Q1 2026.

• In Q1 2026, Enterprise Value fell 49.16% year-over-year to -$209.8 million; the TTM figure through Mar 2026 stood at -$209.8 million (down 49.16% YoY), while the FY2025 annual figure was -$162.2 million, down 6.1% from the prior year.
• Enterprise Value for Q1 2026 stood at -$209.8 million, down from -$172.9 million in the prior quarter.
• The five-year high for Enterprise Value was -$135.7 million in Q4 2023, with the low at -$247.8 million in Q2 2022.
• The 5-year median for Enterprise Value is -$172.9 million (2025), against an average of -$177.6 million.
• The sharpest annual moves came in 2023 and 2026: Enterprise Value surged 32.31% in 2023, then slumped 49.16% in 2026.
• Bio-Techne's Enterprise Value stood at -$196.8 million in 2022, then surged by 31.06% to -$135.7 million in 2023, then plunged by 30.89% to -$177.5 million in 2024, then grew by 2.63% to -$172.9 million in 2025, then slipped by 21.37% to -$209.8 million in 2026.
• Business Quant data shows TECH's Enterprise Value at -$209.8 million in Q1 2026, -$172.9 million in Q4 2025, and -$145.0 million in Q3 2025.